FDA lifts partial hold on Mersana cancer drug trial, but shares fall

The partial hold was put in place in July after it was determined that a patient's death may have been linked to the drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.